Regen Biopharma Inc (OTCMKTS: RGBP) Gets Approval for Cancer Vaccine Patent
Regen Biopharma Inc (OTCMKTS: RGBP) had its antigen-specific mRNA cellular cancer vaccine patent approved on August 17. The announcement is to be made when the company goes pink current. Regen…